封面
市场调查报告书
商品编码
1304308

电感受态细胞市场:各用途,各细胞类型,性状转换效率,各包装型态,各终端用户,各地区- 市场规模,占有率,展望,机会分析,2023-2030年

Electrocompetent Cells Market,By Application, By Cell Type, By Transformation Efficiency, By Packaging Format, By End-User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

市场动态:

分子克隆研究的研究活动和资助活动有所增加。这反过来预计将增加对感受态细胞的需求,因为感受态细胞在各种生物技术程序中非常有效。这一因素预计将支持预测期内全球电感受态细胞市场的增长。

然而,对具有良好技术知识的熟练专业人员的需求是预计在预测期内阻碍全球电感受态细胞市场增长的主要因素之一。

本调查的主要特征

  • 本报告提供以2021年为基准年的预测期间(2022-2030 年)之全球电感受态细胞市场的市场规模和復合年增长率(CAGR %)相关的详细分析。
  • 并阐明不同部门市场的潜在收入机会,说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点,各类型投资组合、主要焦点、财务业绩和市场策略等参数,介绍全球电感受态细胞市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察,将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球电感受态细胞市场报告配合该行业的各种利益相关者,包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球电感受态细胞市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称

第2章 市场概况

  • 报告概要
    • 市场定义和范围
  • 摘要整理
  • 连贯·机遇·地图(COM)

第3章 市场动态,法规,趋势分析

  • 市场动态
    • 促进因素
  • 分子克隆研究的研究和资助活动的增加
  • 增加对基因治疗的投资
    • 阻碍因素
  • 缺乏熟练的专业人员
    • 机会
  • 重组DNA技术的进步
  • 影响分析
  • 主要的焦点
  • 法规情势
  • 产品上市/核准
  • PEST分析
  • 波特分析
  • 合併·收购情势

第4章 全球电感受态细胞市场-冠状病毒(COVID-19)大流行病的影响

  • COVID-19流行病学
  • 供给面和需求面的分析
  • 经济影响

第5章 电感受态细胞的全球市场,各用途,2023-2030年

  • 基因复製
  • 蛋白质表现
  • 突然变异诱发
  • 基因DNA库建立
  • 抗体产生
  • 高通量·筛检
  • 其他

第6章 电感受态细胞的全球市场,各细胞类型,2023-2030年

  • 大肠桿菌(E. coli)
  • 酿酒酵母(S. cerevisiae)
  • 枯草芽孢桿菌(B. subtilis)
  • 恶臭假单胞菌(P. putida)
  • 肺炎链球菌(S.pneumoniae)
  • 其他

第7章 电感受态细胞的全球市场,性状转换效率,2023-2030年

  • 高效率细胞
  • 超高效率细胞

第8章 电感受态细胞的全球市场:各包装型态,2023-2030年

  • 自订格式

第9章 电感受态细胞的全球市场:各终端用户,2023-2030年

  • 製药·生物科技企业
  • 学术·研究机关
  • 临床研究委外机构(CRO)
  • 其他

第10章 电感受态细胞的全球市场,各地区,2023-2030年

  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲

第11章 竞争情形

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • New England Biolabs, Inc.
  • GenScript Biotech Corporation
  • Lucigen Corporation
  • Takara Bio Inc.
  • Delphi Genetics S.A.

第12章 章节

  • 调查手法
  • 关于出版社
简介目录
Product Code: CMI5897

Electrocompetent cells are bacterial strains that are capable of receiving and transferring foreign DNA by the process of electrotransformation. They are typically prepared by a time-consuming and labor-intensive method that involves extensive washing and centrifugation, as well as maintaining the cells at an ice-cold temperature. The traditional procedure also results in a low transformation efficiency, making it difficult to generate high quality clones using this technique.

Market Dynamics:

There is a rise in research activities and funding activities in molecular cloning studies. This in turn is expected to boost the demand for competent cells as they are highly efficacious in various biotechnology procedures. This factor is expected to support growth of the global electrocompetent cells market over the forecast period.

However, the need for skilled professionals having sound technical knowledge is one of the major factors expected to hamper growth of the global electrocompetent cells market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global electrocompetent cells market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global electrocompetent cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), and Cell Applications, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global electrocompetent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electrocompetent cells market

Detailed Segmentation:

  • Global Electrocompetent Cells Market, By Application:
    • Cloning
    • Protein Expression
    • Mutagenesis
    • Genomic DNA Library Construction
    • Antibody Production
    • High-Throughput Screening
    • Others
  • Global Electrocompetent Cells Market, By Cell Type
    • Escherichia coli (E. coli)
    • Saccharomyces cerevisiae (S. cerevisiae)
    • Bacillus subtilis (B. subtilis)
    • Pseudomonas putida (P. putida)
    • Streptococcus pneumoniae (S. pneumoniae)
    • Others
  • Global Electrocompetent Cells Market, By Transformation Efficiency:
    • High Efficiency Cells
    • Ultra-High Efficiency Cells
  • Global Electrocompetent Cells Market, By Packaging Format:
    • Tubes
    • Plates
    • Custom Formats
  • Global Electrocompetent Cells Market, By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Contract Research Organizations (CROs)
    • Others
  • Global Electrocompetent Cells Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • QIAGEN N.V.
    • Bio-Rad Laboratories, Inc.
    • New England Biolabs, Inc.
    • GenScript Biotech Corporation
    • Lucigen Corporation
    • Takara Bio Inc.
    • Delphi Genetics S.A.
    • IBA GmbH
    • Scarab Genomics LLC
    • Zymo Research Corporation
    • Bioline GmbH (Meridian Bioscience)
    • Cell Applications, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By Cell Type
    • Market Snapshot, By Transformation Efficiency
    • Market Snapshot, By Packaging Format
    • Market Snapshot, By End User
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rise in research activities and funding activities in molecular cloning studies
  • Increasing investments in gene therapy
    • Restraints
  • Lack of skilled professionals
    • Opportunities
  • Advancements in recombinant DNA technology
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Electrocompetent Cells Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Electrocompetent Cells Market , By Application, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Cloning
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Protein Expression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Mutagenesis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Genomic DNA Library Construction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Antibody Production
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • High-Throughput Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Electrocompetent Cells Market , By Cell Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Escherichia coli (E. coli)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Saccharomyces cerevisiae (S. cerevisiae)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Bacillus subtilis (B. subtilis)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Pseudomonas putida (P. putida)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Streptococcus pneumoniae (S. pneumoniae)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

7. Global Electrocompetent Cells Market , By Transformation Efficiency, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • High Efficiency Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Ultra-High Efficiency Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

8. Global Electrocompetent Cells Market , By Packaging Format, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Tubes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Plates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Custom Formats
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

9. Global Electrocompetent Cells Market , By End User, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

10. Global Electrocompetent Cells Market , By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)

11. Competitive Landscape

  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
  • Agilent
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • New England Biolabs, Inc.
  • GenScript Biotech Corporation
  • Lucigen Corporation
  • Takara Bio Inc.
  • Delphi Genetics S.A.
  • Analyst Views

12. Section

  • Research Methodology
  • About us